By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Clearside Biomedical 

1220 Old Alpharetta Road
Suite 300
Alpharetta   Georgia  30005  U.S.A.
Phone: 678-270-3631 Fax:



Company News
Clearside Biomedical To Present Research On Proprietary Retinal Therapeutics Platform At 2014 Association for Research in Vision & Ophthalmology Meeting 5/2/2014 9:45:19 AM
Clearside Biomedical Announces Third Patent Allowance In The U.S. Related To Proprietary Microneedle Drug Delivery Methods And Devices 1/29/2014 9:25:45 AM
Clearside Biomedical Names Glenn Noronha, Ph.D., Executive Vice President, Research and Development 8/5/2013 6:53:52 AM
Clearside Biomedical Announces Appointment of Gerald D. Cagle, Ph.D. to Board of Directors 7/22/2013 6:36:55 AM
Clearside Biomedical to Present Research on Proprietary Retinal Therapeutics Platform at 2013 Association for Research in Vision & Ophthalmology Meeting 5/1/2013 7:42:56 AM
Santen Pharmaceutical and Clearside Biomedical Enter Into Financing and Research Collaboration Agreements for Posterior Ocular Disease 1/31/2013 10:18:08 AM
Clearside Biomedical Announces Plans for Clinical Testing of CLS1001 (Triamcinolone Acetonide) Suprachoroidal Injectable Suspension for the Treatment of Some Eye Diseases 1/10/2013 9:30:39 AM
Clearside Biomedical Names Charles Deignan Chief Financial Officer 10/29/2012 6:29:32 AM